Clinical Trial Information
ContraMed is actively recruiting clinical study participants in a number of U.S. cities. To learn more, please visit https://clinicaltrials.gov/ct2/show/NCT02446821.
Clinical Study Title: Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
ClinicalTrials.gov Identifier: NCT02446821
CAUTION: New Drug- Limited by Federal Law to Investigational Use.